New Round of State Lawsuits and a Federal FDA Update Put Medication Abortion Access at Center of US Policy Fight
On October 19, 2026 several state actions and an ongoing federal review focused attention on medication abortion, as lawsuits seek to curb telehealth prescriptions of mifepristone and the Food and Drug Administration faces a court deadline to report on its safety review.
